{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:21:09Z","timestamp":1793643669114,"version":"4.5.1"},"reference-count":55,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:00:00Z","timestamp":1711756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC)","award":["CB21\/13\/00009"],"award-info":[{"award-number":["CB21\/13\/00009"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC)","award":["CB21\/13\/00079"],"award-info":[{"award-number":["CB21\/13\/00079"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC)","award":["CB21\/13\/00054"],"award-info":[{"award-number":["CB21\/13\/00054"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC)","award":["CB21\/13\/00086"],"award-info":[{"award-number":["CB21\/13\/00086"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>This large, multicenter, retrospective cohort study including onco-hematological neutropenic patients with Pseudomonas aeruginosa bloodstream infection (PABSI) found that among 1213 episodes, 411 (33%) presented with septic shock. The presence of solid tumors (33.3% vs. 20.2%, p &lt; 0.001), a high-risk Multinational Association for Supportive Care in Cancer (MASCC) index score (92.6% vs. 57.4%; p &lt; 0.001), pneumonia (38% vs. 19.2% p &lt; 0.001), and infection due to multidrug-resistant P. aeruginosa (MDRPA) (33.8% vs. 21.1%, p &lt; 0.001) were statistically significantly higher in patients with septic shock compared to those without. Patients with septic shock were more likely to receive inadequate empirical antibiotic therapy (IEAT) (21.7% vs. 16.2%, p = 0.020) and to present poorer outcomes, including a need for ICU admission (74% vs. 10.5%; p &lt; 0.001), mechanical ventilation (49.1% vs. 5.6%; p &lt; 0.001), and higher 7-day and 30-day case fatality rates (58.2% vs. 12%, p &lt; 0.001, and 74% vs. 23.1%, p &lt; 0.001, respectively). Risk factors for 30-day case fatality rate in patients with septic shock were orotracheal intubation, IEAT, infection due to MDRPA, and persistent PABSI. Therapy with granulocyte colony-stimulating factor and BSI from the urinary tract were associated with improved survival. Carbapenems were the most frequent IEAT in patients with septic shock, and the use of empirical combination therapy showed a tendency towards improved survival. Our findings emphasize the need for tailored management strategies in this high-risk population.<\/jats:p>","DOI":"10.3390\/microorganisms12040705","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T13:44:52Z","timestamp":1711892692000},"page":"705","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2554-4656","authenticated-orcid":false,"given":"Cristina","family":"Royo-Cebrecos","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Hospital Nostra Senyora de Meritxell, SAAS, AD700 Escaldes-Engordany, Andorra"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-7231","authenticated-orcid":false,"given":"J\u00falia","family":"Laporte-Amarg\u00f3s","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, 08907 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pe\u00f1a","sequence":"additional","affiliation":[{"name":"Haematology Department, Institute Catal\u00e0 d\u2019Oncologia (ICO)\u2013Hospital Duran i Reynals, IDIBELL, 08908 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3743-2379","authenticated-orcid":false,"given":"Isabel","family":"Ruiz-Camps","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Vall d\u2019Hebron University Hospital, 08035 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-0683","authenticated-orcid":false,"given":"Carolina","family":"Garcia-Vidal","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Cl\u00ednic i Provincial, 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson","family":"Abdala","sequence":"additional","affiliation":[{"name":"Instituto do Cancer do Estado de S\u00e3o Paulo, Faculty of Medicine, Univesity of S\u00e3o Paulo, Sao Paulo 01246, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Oltolini","sequence":"additional","affiliation":[{"name":"Unit of Infectious and Tropical Diseases, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Akova","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Hacettepe University School of Medicine, 06100 Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Montejo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Cruces University Hospital, 48903 Bilbao, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Ospedale Policlinico San Martino, University of Genoa (DISSAL), 16132 Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Mart\u00edn-D\u00e1vila","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Ramon y Cajal Hospital, 28034 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabi\u00e1n","family":"Herrera","sequence":"additional","affiliation":[{"name":"Infectious Diseases Section, Department of Medicine, Centro de Educaci\u00f3n M\u00e9dica e Investigaciones Cl\u00ednicas (CEMIC), Buenos Aires C1430EFA, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Gasch","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Parc Taul\u00ed, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed (I3PT-CERCA), Universitat Aut\u00f2noma de Barcelona, 08208 Sabadell, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubos","family":"Drgona","sequence":"additional","affiliation":[{"name":"Oncohematology Department, National Cancer Institute, Comenius University, 81499 Bratislava, Slovakia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Manuel Paz","family":"Morales","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Erasto Gaertner, Curitiba 81520-060, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Brunel","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Medicine Department, Lausanne University Hospital, CHUV, 1011 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Haematology Department, Reina Sof\u00eda University Hospital-IMIBIC-UCO, 14004 C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Isler","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, Istanbul Education and Research Hospital, 34668 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried V.","family":"Kern","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine II, Faculty of Medicine, University of Freiburg Medical Center, 79110 Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1713-6807","authenticated-orcid":false,"given":"Zaira R.","family":"Palacios-Baena","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases and Clinical Microbiology, Institute of Biomedicine of Seville (IBIS), Virgen Macarena University Hospital, 41013 Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo Maestr","family":"de la Calle","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Instituto de Investigaci\u00f3n Hospital \u201c12 de Octubre\u201d (i + 12), School of Medicine, \u201c12 de Octubre\u201d University Hospital, Universidad Complutense, 28041 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Milagro","family":"Montero","sequence":"additional","affiliation":[{"name":"Infectious Pathology and Antimicrobials Research Group (IPAR), Infectious Diseases Service, Hospital del Mar, Institut Hospital del Mar d\u2019Investigations M\u00e8diques (IMIM), Universitat Aut\u00f2noma de Barcelona (UAB), CEXS-Universitat Pompeu Fabra, 08003 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6413-3396","authenticated-orcid":false,"given":"Souha S.","family":"Kanj","sequence":"additional","affiliation":[{"name":"Infectious Diseases Division, American University of Beirut Medical Center, Beirut 110236, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oguz R.","family":"Sipahi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Ege University, 35040 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebnem","family":"Calik","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, University of Health Science Izmir Bozyaka Training and Research Hospital, 35170 Izmir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"M\u00e1rquez-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Regional de M\u00e1laga, 29010 M\u00e1laga, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-5076","authenticated-orcid":false,"given":"Jorge I.","family":"Marin","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Clinical Microbiology Department, Cl\u00ednica Maraya, Manizales 170001-17, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa Z. R.","family":"Gomes","sequence":"additional","affiliation":[{"name":"Hospital Federal dos Servidores do Estado, Instituto Oswaldo Cruz, Fundac\u0327\u00e3o Oswaldo Cruz, Minist\u00e9rio da Sa\u00fade, Rio de Janeiro 20221-161, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Hemmatii","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Academic Teaching Hospital of Charit\u00e9 University Medical School, 10117 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Araos","sequence":"additional","affiliation":[{"name":"Instituto de Ciencias e Innovaci\u00f3n en Medicina, Facultad de Medicina Cl\u00ednica Alemana Universidad del Desarrollo, Santiago de Chile 12461, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4640-679X","authenticated-orcid":false,"given":"Maddalena","family":"Peghin","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5402-3334","authenticated-orcid":false,"given":"Jose L.","family":"Del Pozo","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Microbiology Unit, Navarra University Clinic, 31008 Pamplona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrecia","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Haematology Department, Marqu\u00e9s de Valdecilla University Hospital, 39008 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tilley","sequence":"additional","affiliation":[{"name":"Microbiology Department, University Hospitals Plymouth NHS Trust, Plymouth PL6 8DH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Manzur","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Hospital Rawson, San Juan J5400, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Novo","sequence":"additional","affiliation":[{"name":"Haematology Department, Son Espases University Hospital, 07120 Palma de Mallorca, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-2563","authenticated-orcid":false,"given":"Jordi","family":"Carratal\u00e0","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, 08907 Barcelona, Spain"},{"name":"Faculty of Medicine, Bellvitge Campus, University of Barcelona, carrer de la Feixa Llarga, s\/n, 08907 Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Gudiol","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Bellvitge University Hospital, IDIBELL, 08907 Barcelona, Spain"},{"name":"Faculty of Medicine, Bellvitge Campus, University of Barcelona, carrer de la Feixa Llarga, s\/n, 08907 Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain"},{"name":"Infectious Diseases Unit, Catalan Institute of Oncology (ICO), Duran i Reynals Hospital, IDIBELL, 08908 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","article-title":"Changing Etiology, Clinical Features, Antimicrobial Resistance, and Outcomes of Bloodstream Infection in Neutropenic Cancer Patients","volume":"19","author":"Gudiol","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream Infections in Neutropenic Cancer Patients: A Practical Update","volume":"7","author":"Gustinetti","year":"2016","journal-title":"Virulence"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","article-title":"Aetiology and Resistance in Bacteraemias among Adult and Paediatric Haematology and Cancer Patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jinf.2016.07.002","article-title":"Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies","volume":"73","author":"Satlin","year":"2016","journal-title":"J. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/427329","article-title":"Infections in Patients with Febrile Neutropenia: Epidemiology, Microbiology, and Risk Stratification","volume":"40","author":"Viscoli","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00277-012-1424-3","article-title":"P. aeruginosa Bloodstream Infections among Hematological Patients: An Old or New Question?","volume":"91","author":"Cattaneo","year":"2012","journal-title":"Ann. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","article-title":"Risk of Bacteraemia and Mortality in Patients with Haematological Malignancies","volume":"12","author":"Larsson","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2010.036640","article-title":"Multidrug Resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients with Hematologic Malignancies","volume":"96","author":"Trecarichi","year":"2011","journal-title":"Haematologica"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmi.2019.07.002","article-title":"Predictors of Multidrug-Resistant Pseudomonas aeruginosa in Neutropenic Patients with Bloodstream Infection","volume":"26","author":"Viasus","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kim, H.S., Park, B.K., Kim, S.K., Han, S.B., Lee, J.W., Lee, D.-G., Chung, N.G., Cho, B., Jeong, D.C., and Kang, J.H. (2017). Clinical Characteristics and Outcomes of Pseudomonas aeruginosa Bacteremia in Febrile Neutropenic Children and Adolescents with the Impact of Antibiotic Resistance: A Retrospective Study. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2597-0"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2017.05.003","article-title":"Pseudomonas aeruginosa Bacteraemia in Patients with Hematologic Malignancies: Risk Factors, Treatment and Outcome","volume":"88","author":"Tofas","year":"2017","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/ciz319","article-title":"Inappropriate Empirical Antibiotic Treatment in High-Risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance","volume":"70","author":"Gudiol","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1165\/rcmb.2017-0321TR","article-title":"Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections","volume":"58","author":"Maurice","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Thi, M.T.T., Wibowo, D., and Rehm, B.H.A. (2020). Pseudomonas aeruginosa Biofilms. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228671"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","article-title":"Antibiotic Resistance of Bacteria in Biofilms","volume":"358","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4248\/IJOS11026","article-title":"The Clinical Impact of Bacterial Biofilms","volume":"3","author":"Ciofu","year":"2011","journal-title":"Int. J. Oral Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European Guidelines for Empirical Antibacterial Therapy for Febrile Neutropenic Patients in the Era of Growing Resistance: Summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.eimc.2019.01.013","article-title":"Executive Summary of the Consensus Document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the Management of Febrile Neutropenia in Patients with Hematological Malignancies","volume":"38","author":"Gudiol","year":"2020","journal-title":"Enfermedades Infecc. Microbiol. Clin. Engl. Ed."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/jac\/dkac135","article-title":"Resistance to Empirical \u03b2-Lactams Recommended in Febrile Neutropenia Guidelines in Gram-Negative Bacilli Bloodstream Infections in Spain: A Multicentre Study","volume":"77","author":"Chumbita","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e00674-23","DOI":"10.1128\/spectrum.00674-23","article-title":"High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia Following International Guideline Recommendations","volume":"11","author":"Chumbita","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2016.0289","article-title":"Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Phillips","year":"2016","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and Septic Shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1128\/AAC.01744-21","article-title":"Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock","volume":"66","author":"Chumbita","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e02494-19","DOI":"10.1128\/AAC.02494-19","article-title":"Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa","volume":"64","author":"Gudiol","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","unstructured":"(2023, October 09). Eucast: Clinical Breakpoints and Dosing of Antibiotics. Available online: https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC Definitions for Nosocomial Infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am. J. Infect. Control"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Le Borgne, P., Feuillassier, L., Schenck, M., Herbrecht, J.E., Janssen-Langenstein, R., Simand, C., Gantzer, J., Nannini, S., Fornecker, L.M., and Alam\u00e9, K. (2022). Comparison of Short-and Long-Term Mortality in Patients with or without Cancer Admitted to the ICU for Septic Shock: A Retrospective Observational Study. Cancers, 14.","DOI":"10.3390\/cancers14133196"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e00283-22","DOI":"10.1128\/iai.00283-22","article-title":"Sex and Gender Differences in Bacterial Infections","volume":"90","author":"Dias","year":"2022","journal-title":"Infect. Immun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40121-017-0146-1","article-title":"Infections in Cancer Patients with Solid Tumors: A Review","volume":"6","author":"Rolston","year":"2017","journal-title":"Infect. Dis. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1513\/AnnalsATS.201909-655OC","article-title":"Improvements in Sepsis-Associated Mortality in Hospitalized Patients with Cancer versus Those without Cancer: A 12-Year Analysis Using Clinical Data","volume":"17","author":"Cooper","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Albasanz-Puig, A., Dur\u00e0-Miralles, X., Laporte-Amarg\u00f3s, J., Mussetti, A., Ruiz-Camps, I., Puerta-Alcalde, P., Abdala, E., Oltolini, C., Akova, M., and Montejo, J.M. (2022). Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia. Microorganisms, 10.","DOI":"10.3390\/microorganisms10040733"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/resp.12848","article-title":"Clinical Features, Aetiology and Outcome of Bacteraemic Pneumonia in Neutropenic Cancer Patients","volume":"21","author":"Gudiol","year":"2016","journal-title":"Respirology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jinf.2010.10.010","article-title":"Risk Factors and Pathogenic Significance of Severe Sepsis and Septic Shock in 2286 Patients with Gram-Negative Bacteremia","volume":"62","author":"Kang","year":"2011","journal-title":"J. Infect."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic Resistance in Pseudomonas aeruginosa: Mechanisms and Alternative Therapeutic Strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Alfei, S. (2024). Shifting from Ammonium to Phosphonium Salts: A Promising Strategy to Develop Next-Generation Weapons against Biofilms. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16010080"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000494069","article-title":"Bacteria-Host Crosstalk: Sensing of the Quorum in the Context of Pseudomonas aeruginosa Infections","volume":"11","author":"Turkina","year":"2019","journal-title":"J. Innate Immun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e02292-21","DOI":"10.1128\/spectrum.02292-21","article-title":"Real-Life Use of Ceftolozane\/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: A Matched Control Study (ZENITH Study)","volume":"10","author":"Bergas","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"ofac079","DOI":"10.1093\/ofid\/ofac079","article-title":"A Prospective Randomized Study Comparing Ceftolozane\/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies","volume":"9","author":"Chaftari","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e02340-18","DOI":"10.1128\/AAC.02340-18","article-title":"A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection","volume":"63","author":"Alba","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","first-page":"e02340-18","article-title":"Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: A Propensity-Matched Cohort Study (AMINOLACTAM Study)","volume":"65","author":"Gudiol","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/CCM.0000000000004322","article-title":"Sepsis and Septic Shock in Patients with Malignancies: A Groupe de Recherche Respiratoire En R\u00e9animation Onco-H\u00e9matologique Study","volume":"48","author":"Lemiale","year":"2020","journal-title":"Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1001\/jama.1993.03500210038025","article-title":"Critically Ill Cancer Patients: Benefit and Expense","volume":"269","author":"Ostenson","year":"1993","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1097\/00003246-200111000-00014","article-title":"Compliance with Triage to Intensive Care Recommendations","volume":"29","author":"Azoulay","year":"2001","journal-title":"Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2110-5820-1-5","article-title":"Intensive Care of the Cancer Patient: Recent Achievements and Remaining Challenges","volume":"1","author":"Azoulay","year":"2011","journal-title":"Ann. Intensive Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/CCM.0b013e318232646b","article-title":"Improving Survival in Critically Ill Patients with Cancer: The Door Is Still Open","volume":"40","author":"Soares","year":"2012","journal-title":"Crit. Care Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cam4.430","article-title":"Intensive Care Admission of Cancer Patients: A Comparative Analysis","volume":"4","author":"Bos","year":"2015","journal-title":"Cancer Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Biskup, E., Cai, F., Vetter, M., and Marsch, S. (2017). Oncological Patients in the Intensive Care Unit: Prognosis, Decision-Making, Therapies and End-of-Life Care. Swiss Med. Wkly., 147.","DOI":"10.4414\/smw.2017.14557"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","article-title":"2010 Update of EORTC Guidelines for the Use of Granulocyte-Colony Stimulating Factor to Reduce the Incidence of Chemotherapy-Induced Febrile Neutropenia in Adult Patients with Lymphoproliferative Disorders and Solid Tumours","volume":"47","author":"Aapro","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.6004\/jnccn.2021.7046","article-title":"Outcomes and Predictors of 28-Day Mortality in Patients with Hematologic Malignancies and Septic Shock Defined by Sepsis-3 Criteria","volume":"20","author":"Manjappachar","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13054-018-2076-z","article-title":"Influence of Neutropenia on Mortality of Critically Ill Cancer Patients: Results of a Meta-Analysis on Individual Data","volume":"22","author":"Georges","year":"2018","journal-title":"Crit. Care"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/4\/705\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:21:22Z","timestamp":1760106082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/12\/4\/705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,30]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["microorganisms12040705"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms12040705","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,30]]}}}